Profile
- Teaching programs for students in medicine and biomedical sciences (BMS), supervision of bachelor and master students for their elective modules and master thesis, supervision and mentoring of PhD students for Cellular and Biomedical Science (GCB)
- Six research groups
- Investigation of the mechanism that contributes to renal function loss upon hypoxia and chronic allograft failure, formation of kidney stones, development of renal fibrosis and atherosclerosis, as well as factors influencing the steroid hormone metabolome
- Aim: improving diagnostic tools and implementing novel therapeutic approaches to enhance patient care
External Partners
Department of Chemistry and Biochemistry, University of Bern, Switzerland; Institute of Biochemistry and Molecular Medicine, University of Bern, Switzerland; Department of Pharmacology and Toxicology, University of Lausanne, Switzerland; Institute of Social and Preventive Medicine, University of Lausanne, Switzerland; Institute of Pharmaceutical Sciences of Western Switzerland, Geneva, Switzerland; Institut des Cordeliers, Collège de France, Paris, France; Department of Biochemistry and Biophysics, Stockholm, Sweden; University of Nottingham, Nottingham, UK; University of Cambridge, Cambridge, UK; Università Cattolica del sacro Cuore, Rome, Italy; University of Stellenbosch, South Africa; University of Texas Southwestern Medical Center, Division of Nephrology, Dallas, USA; Johns Hopkins University, Department of Physiology, Baltimore, USA
Grants
- Swiss National Foundation (10030_182482; 310030_172974; 310030_204972; 310030_215719; 331C30_166785; 4078P0_198281)
- Sinergia (CRSII5_180326)
- Boehringher Ingelheim
- Vifor Pharma
- SF Board Call, Faculty of Medicine, University of Bern
- Center for Artificial Intelligence in Medicine, University of Bern
- Unrestricted Research Grant CSL Vifor
- CSL Behring RAI continuation grant
